Thursday, April 23, 2026

‘We Are NOT Ready for Dialogue’—Are You Still Coming, Mr. Trump? The Nuclear Blackmail Kim Sent

North Korea's missile tests signal rejection of dialogue with Trump, showcasing military capability ahead of APEC summit.

Hyundai Boosts EV Safety, Produces Ioniq 9 in U.S. to Counter Tariff Pressures and Rival Kia

Hyundai will exclusively produce the Ioniq 9 SUV in the U.S. to avoid tariffs, targeting 6,500 units in South Korea.

Prison State Reality: North Korean Citizens Ordered to Change Their ‘Moral Character’ for the Party

Kim Jong Un commemorates the Workers' Party's 80th anniversary, emphasizing unity and transformation for future socialist development.

Yu Ri Cho

Author's Latest

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

AITRICS establishes first AI ethics checklist in healthcare

AITRICS develops the first AI ethics checklist for healthcare, ensuring compliance with ethical standards in medical AI applications.

Coreline Soft Secures Major AI Contract with Italy’s National Cancer Center for Lung Cancer Early Detection

Coreline Soft renews its contract for AVIEW LCS Plus with Italy's National Cancer Center, enhancing early lung cancer diagnosis via AI.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

22,700 Deaths Highlight a Growing Antibiotic Resistance Crisis

Antibiotic resistance poses a severe threat, especially in nursing homes. Awareness and reduced usage are crucial to combat this growing crisis.

CG MedTech Acquires Human Tissue Processing Bank: What This Means for the Bio Sector in 2026

CG MedTech acquires a human tissue processing bank, expanding into bio business with ECM-based therapeutics and dental materials.

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

GC Biopharma Develops Innovative Method to Enhance Immunoglobulin Safety

GC녹십자 developed a method to detect impurities that can cause blood clots in the production of intravenous immunoglobulin.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug Control Law

Authorities found widespread narcotics violations in medical institutions using propofol, with over half inspected breaching regulations.

How ExcelOs Inject Revolutionizes Bone Grafting: Insights from the Latest GBR Seminar

CGBIO hosted a hands-on seminar for dental professionals, focusing on practical skills in maxillary sinus lifts and bone grafting techniques.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.